- Home
- BCSF vs ATRC Comparison
BCSF vs ATRC Comparison
Compare BCSF & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCSF
- ATRC
- Stock Information
- Founded
- BCSF 2015
- ATRC 2000
- Country
- BCSF United States
- ATRC United States
- Employees
- BCSF N/A
- ATRC N/A
- Industry
- BCSF Finance/Investors Services
- ATRC Medical/Dental Instruments
- Sector
- BCSF Finance
- ATRC Health Care
- Exchange
- BCSF Nasdaq
- ATRC Nasdaq
- Market Cap
- BCSF 1.1B
- ATRC 1.1B
- IPO Year
- BCSF 2018
- ATRC 2005
- Fundamental
- Price
- BCSF $17.28
- ATRC $34.69
- Analyst Decision
- BCSF Hold
- ATRC Strong Buy
- Analyst Count
- BCSF 4
- ATRC 9
- Target Price
- BCSF $16.75
- ATRC $41.78
- AVG Volume (30 Days)
- BCSF 194.9K
- ATRC 465.9K
- Earning Date
- BCSF 02-25-2025
- ATRC 02-13-2025
- Dividend Yield
- BCSF 10.40%
- ATRC N/A
- EPS Growth
- BCSF N/A
- ATRC N/A
- EPS
- BCSF 1.99
- ATRC N/A
- Revenue
- BCSF $294,257,000.00
- ATRC $447,573,000.00
- Revenue This Year
- BCSF N/A
- ATRC $17.75
- Revenue Next Year
- BCSF N/A
- ATRC $13.44
- P/E Ratio
- BCSF $8.70
- ATRC N/A
- Revenue Growth
- BCSF 3.17
- ATRC 17.56
- 52 Week Low
- BCSF $14.78
- ATRC $18.94
- 52 Week High
- BCSF $17.97
- ATRC $39.05
- Technical
- Relative Strength Index (RSI)
- BCSF 51.57
- ATRC 59.50
- Support Level
- BCSF $16.79
- ATRC $31.00
- Resistance Level
- BCSF $17.80
- ATRC $34.11
- Average True Range (ATR)
- BCSF 0.28
- ATRC 1.49
- MACD
- BCSF -0.06
- ATRC 0.48
- Stochastic Oscillator
- BCSF 41.53
- ATRC 77.07
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes, First Lien Senior Secured Loan, Preferred Equity, Equity Interest, and Second Lien Senior Secured Loan among others.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.